1999
DOI: 10.1006/nbdi.1999.0247
|View full text |Cite
|
Sign up to set email alerts
|

Evidence That Aβ42 Plasma Levels in Presenilin-1 Mutation Carriers Do not Allow for Prediction of Their Clinical Phenotype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
1

Year Published

2000
2000
2018
2018

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 42 publications
(19 citation statements)
references
References 38 publications
0
18
1
Order By: Relevance
“…Among these mutations, the PS1 L166P mutation is of particular interest because it is associated with disease onset in adolescence. Moreover, the L166P mutation causes an exceptional increase in the A␤ 42 ͞ A␤ total ratio, similar to the FAD-associated PS1 G384A mutation (11,36). This extreme increase of A␤ 42 may be due to disruption of TM3 by the helix-breaking proline.…”
Section: Discussionmentioning
confidence: 91%
“…Among these mutations, the PS1 L166P mutation is of particular interest because it is associated with disease onset in adolescence. Moreover, the L166P mutation causes an exceptional increase in the A␤ 42 ͞ A␤ total ratio, similar to the FAD-associated PS1 G384A mutation (11,36). This extreme increase of A␤ 42 may be due to disruption of TM3 by the helix-breaking proline.…”
Section: Discussionmentioning
confidence: 91%
“…1C, Table 1). The catalytic motif mutant, mIAP G219A , adjacent to the aspartate in GxG 219 D, and the site of the familial Alzheimer disease (FAD) mutant G384A in presenilin (29,30), exhibits catalytic rates similar to mIAP Y161A (Table 1). Previous studies of the G384A presenilin variant (31) and corresponding variant in other SPP homologs (11,32) detected reduced end product via immunoblot.…”
Section: Resultsmentioning
confidence: 99%
“…However, the mechanism underlying the decrease in CSF-Aß 42 in dementia disorders is currently unclear and only tentative conclusions can be drawn as to the etiology. The fact that Aß 42 has been found in plasma [57] raises the question of the source of Aß 42 in the CSF. Furthermore, no study has hitherto investigated the CSF levels of Aß 42 premortem in AD cases that were diagnostically verified postmortem.…”
Section: Discussionmentioning
confidence: 99%